Outbreak and Management Strategies of Nipah Virus: A Scenario from the Southern Part of India
- Авторлар: Gupta M.1, Mukherjee T.1, Mohanty S.1
-
Мекемелер:
- Division of Pharmacology, Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra
- Шығарылым: Том 24, № 8 (2024)
- Бөлім: Medicine
- URL: https://ter-arkhiv.ru/1871-5265/article/view/645759
- DOI: https://doi.org/10.2174/0118715265299783240402063101
- ID: 645759
Дәйексөз келтіру
Толық мәтін
Авторлар туралы
Muskan Gupta
Division of Pharmacology, Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra
Email: info@benthamscience.net
Tuhin Mukherjee
Division of Pharmacology, Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra
Email: info@benthamscience.net
Satyajit Mohanty
Division of Pharmacology, Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra
Хат алмасуға жауапты Автор.
Email: info@benthamscience.net
Әдебиет тізімі
- Srivastava S, Deb N, Roy P, et al. Recent Nipah virus outbreak in India: Lessons and imperatives. Ther Adv Infect Dis 2023; 10: 20499361231208535. doi: 10.1177/20499361231208535 PMID: 37842170
- Uwishema O, Wellington J, Berjaoui C, Muoka KO, Onyeaka CVP, Onyeaka H. A short communication of Nipah virus outbreak in India: An urgent rising concern. Ann med surg 2022; 82: 104599. doi: 10.1016/j.amsu.2022.104599
- Banerjee S, Gupta N, Kodan P, et al. Nipah virus disease: A rare and intractable disease. Intractable Rare Dis Res 2019; 8(1): 1-8. doi: 10.5582/irdr.2018.01130 PMID: 30881850
- Playford EG, Munro T, Mahler SM, et al. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: A first-in-human, randomised, controlled, phase 1 study. Lancet Infect Dis 2020; 20(4): 445-54. doi: 10.1016/S1473-3099(19)30634-6 PMID: 32027842
- Soman Pillai V, Krishna G, Valiya Veettil M. Nipah virus: Past outbreaks and future containment. Viruses 2020; 12(4): 465. doi: 10.3390/v12040465 PMID: 32325930
- Yadav PD, Sahay RR, Balakrishnan A, et al. Nipah virus outbreak in kerala state, india amidst of COVID-19 pandemic. Front Public Health 2022; 10: 818545. doi: 10.3389/fpubh.2022.818545 PMID: 35252095
- Thiagarajan K. Nipah virus: Indias Kerala state moves quickly to control fresh outbreak. BMJ 2023; 382: 2117. doi: 10.1136/bmj.p2117 PMID: 37714528
- Devnath P, Masud HMAA. Nipah virus: A potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus 2 pandemic. New Microbes New Infect 2021; 41: 100873. doi: 10.1016/j.nmni.2021.100873 PMID: 33758670
- Nipah virus in Kerala: 2 deaths, over 700 people tested. What we know so far about the outbreak. 10 points Available from: https://www.livemint.com/news/india/nipah-virus-in-kerala-2-deaths-over-700-people-tested-what-we-know-so-far-kozhikode-top-developments10-points-11694653182784.html
- What is Nipah virus? Kerala starts mass testing after outbreak in India. Available from: https://www.theguardian.com/world/2023/sep/18/what-is-nipah-virus-kerala-india-bat-borne-outbreak-mass-testing
- Lo MK, Amblard F, Flint M, et al. Potent in vitro activity of β-D-4ʹ-chloromethyl-2ʹ-deoxy-2ʹ-fluorocytidine against Nipah virus. Antiviral Res 2020; 175: 104712. doi: 10.1016/j.antiviral.2020.104712 PMID: 31935422
- Saha R, Mitra S, Halder S, Deb J, Patra A, Sarkar GN. A clinico-epidemiological study of the first outbreak of Nipah virus in Indiareport from ground zero. 2020. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/sea-205355 doi: 10.17511/ijmrr.2020.i03.06
- Nipah: India's Kerala state tests hundreds after fifth case. Available from: https://www.bbc.com/news/world-asia-india-66793836
- Disease outbreak news nipah virus infection India. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON490
Қосымша файлдар
